BR
Therapeutic Areas
Recursion Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| REC-4881 | Familial Adenomatous Polyposis | Phase 2 |
| REC-617 | Advanced Solid Tumors | Phase 1/2 |
| REC-1245 | Biomarker-enriched Solid Tumors and Lymphoma | Phase 1 |
| REC-3565 | B-cell Malignancies | Phase 1 |
| REC-4539 | Solid Tumors and Hematology Oncology | Preclinical |
| Undisclosed Program | Solid Tumors incl. HR+ Breast Cancer | Preclinical |